114/03/02 10:00 - 12:00

-

實體課程

時段	主題	講師	主持人
10:00~11:00	DKD病人衛教介入分享	涂美瑜 營養師 周劍文診所	許碧惠 營養師 台北馬偕醫院
11:00~12:00	Integrative Risk Management in DKD and Diabesity: Bridging Metabolic and Renal Health	廖國盟 醫師 北市聯醫	陳敏玲 秘書長 台灣基層糖尿病協會

●DKD病人衛教介入分享
糖尿病腎病變（Diabetic Kidney Disease, DKD）是糖尿病患者常見且嚴重的併發症，影響腎功能並增加心血管風險。有效的衛教介入能幫助患者改善疾病認知，提升自我管理能力，延緩疾病進展。本演講將分享針對DKD病人的衛教策略，涵蓋疾病知識、血糖與血壓管理、藥物治療、飲食調控及生活習慣改善等關鍵面向。
首先，患者須理解DKD的病理機制，包括高血糖、高血壓與蛋白尿對腎臟的影響。透過圖像化教學與個案分享，可提升患者對腎臟保護的重要性認知。其次，針對血糖與血壓控制，強調個別化治療目標，如HbA1c控制至<7%、血壓控制至<130/80 mmHg，以及減少糖尿病腎病變進展的藥物，如SGLT2抑制劑、GLP-1受體促效劑與礦物皮質類固醇受體拮抗劑（如Finerenone）。
此外，營養衛教是關鍵，建議患者低鹽、低蛋白（依個人腎功能調整）與適量優質蛋白攝取，避免高磷、高鉀食物，並培養閱讀食品標示的習慣。生活方式方面，鼓勵適量運動、戒菸、減少非必要藥物使用（如NSAIDs），並定期監測腎功能與蛋白尿。
最後，本演講將分享實際衛教案例，探討如何提升患者依從性與自我管理能力，運用團隊合作（醫師、護理師、營養師、藥師等）進行多層次介入，讓DKD患者能夠積極參與治療，改善預後並提升生活品質。

●Integrative Risk Management in DKD and Diabesity: Bridging Metabolic and Renal Health
Diabetic kidney disease (DKD) and diabesity—a term reflecting the interplay between diabetes and obesity—are major global health challenges, both significantly increasing cardiovascular and renal risks. Effective risk management requires an integrative approach that addresses metabolic, cardiovascular, and renal health simultaneously. This presentation explores the latest strategies for comprehensive risk mitigation in DKD and diabesity, emphasizing the synergistic effects of emerging therapeutic agents and lifestyle interventions.
A key focus is optimizing glycemic, blood pressure, and lipid control while mitigating renal stress. Recent advancements in pharmacotherapy highlight the complementary benefits of SGLT2 inhibitors and GLP-1 receptor agonists, not only in glucose control but also in reducing cardiorenal events and promoting weight loss. Additionally, the role of non-steroidal mineralocorticoid receptor antagonists, such as finerenone, in reducing inflammation and fibrosis will be discussed.
Beyond pharmacologic interventions, lifestyle modifications, including tailored nutritional strategies and structured exercise programs, remain foundational. The integration of dietary adjustments—such as sodium and protein restriction based on renal function—combined with weight management strategies, contributes to slowing DKD progression. Furthermore, early risk stratification using biomarkers and continuous glucose monitoring (CGM) enhances personalized treatment plans.
This session will also highlight multidisciplinary care models that foster patient engagement and adherence. By bridging metabolic and renal health through evidence-based interventions, we can improve outcomes for patients with DKD and diabesity, ultimately reducing the burden of cardiovascular and kidney complications.

新北凱撒飯店 2F 托斯卡尼廳

-

-

中華民國醫師公會全國聯合會專業2.4積分
中華民國糖尿病學會乙類1分
社團法人中華民國糖尿病衛教學會乙類2分
台灣內科醫學會乙類2分
家醫計畫2.0時數：DKD 2小時
《實際學分數以各醫學會實際通過為主，包含審查中之各醫學會學分》